546 related articles for article (PubMed ID: 9530435)
1. Prostaglandin E receptors in myometrial cells.
Asbóth G; Phaneuf S; López Bernal AL
Acta Physiol Hung; 1997-1998; 85(1):39-50. PubMed ID: 9530435
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 activates phospholipase C and elevates intracellular calcium in cultured myometrial cells: involvement of EP1 and EP3 receptor subtypes.
Asbóth G; Phaneuf S; Europe-Finner GN; Tóth M; Bernal AL
Endocrinology; 1996 Jun; 137(6):2572-9. PubMed ID: 8641211
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
4. Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
Zeng L; An S; Goetzl EJ
J Biol Chem; 1996 Nov; 271(44):27744-50. PubMed ID: 8910368
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 induces Ca2+ release from ryanodine/caffeine-sensitive stores in bovine adrenal medullary cells via EP1-like receptors.
Shibuya I; Tanaka K; Uezono Y; Ueta Y; Toyohira Y; Yanagihara N; Izumi F; Yamashita H
J Neurochem; 1999 Nov; 73(5):2167-74. PubMed ID: 10537077
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues.
Matthews JS; Jones RL
Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586
[TBL] [Abstract][Full Text] [Related]
7. Lack of interaction between prostaglandin E2 receptor subtypes in regulating adenylyl cyclase activity in cultured rat dorsal root ganglion cells.
Wise H
Eur J Pharmacol; 2006 Mar; 535(1-3):69-77. PubMed ID: 16545798
[TBL] [Abstract][Full Text] [Related]
8. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
Jadhav V; Jabre A; Lin SZ; Lee TJ
J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation.
Kay LJ; Yeo WW; Peachell PT
Br J Pharmacol; 2006 Apr; 147(7):707-13. PubMed ID: 16432506
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 induces vascular endothelial growth factor secretion in prostate cancer cells through EP2 receptor-mediated cAMP pathway.
Wang X; Klein RD
Mol Carcinog; 2007 Nov; 46(11):912-23. PubMed ID: 17427962
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the PGE2 receptor subtype in bovine chondrocytes in culture.
de Brum-Fernandes AJ; Morisset S; Bkaily G; Patry C
Br J Pharmacol; 1996 Aug; 118(7):1597-604. PubMed ID: 8842420
[TBL] [Abstract][Full Text] [Related]
12. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
[TBL] [Abstract][Full Text] [Related]
13. EP4/EP2 receptor-specific prostaglandin E2 regulation of interleukin-6 generation by human HSB.2 early T cells.
Zeng L; An S; Goetzl EJ
J Pharmacol Exp Ther; 1998 Sep; 286(3):1420-6. PubMed ID: 9732406
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E receptor subtypes involved in stimulation of gastroduodenal bicarbonate secretion in rats and mice.
Takeuchi K; Ukawa H; Furukawa O; Kawauchi S; Araki H; Sugimoto Y; Ishikawa A; Ushikubi F; Narumiya S
J Physiol Pharmacol; 1999 Jun; 50(2):155-67. PubMed ID: 10424714
[TBL] [Abstract][Full Text] [Related]
15. Cloning of a novel human prostaglandin receptor with characteristics of the pharmacologically defined EP2 subtype.
Regan JW; Bailey TJ; Pepperl DJ; Pierce KL; Bogardus AM; Donello JE; Fairbairn CE; Kedzie KM; Woodward DF; Gil DW
Mol Pharmacol; 1994 Aug; 46(2):213-20. PubMed ID: 8078484
[TBL] [Abstract][Full Text] [Related]
16. Endothelin-induced changes of second messengers in cultured human ciliary muscle cells.
Matsumoto S; Yorio T; Magnino PE; DeSantis L; Pang IH
Invest Ophthalmol Vis Sci; 1996 May; 37(6):1058-66. PubMed ID: 8631621
[TBL] [Abstract][Full Text] [Related]
17. Role of prostaglandin E2 receptors in migration of murine and human breast cancer cells.
Timoshenko AV; Xu G; Chakrabarti S; Lala PK; Chakraborty C
Exp Cell Res; 2003 Oct; 289(2):265-74. PubMed ID: 14499627
[TBL] [Abstract][Full Text] [Related]
18. Expression of prostaglandin receptors EP4 and FP in human lens epithelial cells.
Mukhopadhyay P; Bhattacherjee P; Andom T; Geoghegan TE; Andley UP; Paterson CA
Invest Ophthalmol Vis Sci; 1999 Jan; 40(1):105-12. PubMed ID: 9888433
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E receptor subtypes in cultured rat microglia and their role in reducing lipopolysaccharide-induced interleukin-1beta production.
Caggiano AO; Kraig RP
J Neurochem; 1999 Feb; 72(2):565-75. PubMed ID: 9930728
[TBL] [Abstract][Full Text] [Related]
20. Selective regulation of RNK-16 cell matrix metalloproteinases by the EP4 subtype of prostaglandin E2 receptor.
Zeng L; An S; Goetzl EJ
Biochemistry; 1996 Jun; 35(22):7159-64. PubMed ID: 8679543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]